The COVID-19 pandemic has fundamentally changed the way that medtech companies must approach the sales process in order to ensure revenue growth and deliver the products providers and patients need.

Navigating the intricacies of compliance and risk management can seem overwhelming for businesses, especially those operating in heavily regulated industries. The rules are complex and the stakes are ...